Difficulty: Medium
Average Score: 68%
Practice
Agents, which lower levels of LDL-cholesterol, tend to promote regression of atherosclerotic plaques. This consideration is:
Correct answer
A
Rationale
In the context of pharmacology, agents that lower levels of LDL-cholesterol, such as statins, have been shown to promote regression of atherosclerotic plaques. This is because LDL-cholesterol is a major contributor to the formation and progression of atherosclerosis. By reducing LDL-cholesterol levels, these agents help to decrease the amount of cholesterol that can deposit in arterial walls, leading to a reduction in plaque size and potentially allowing for regression of existing plaques.
Option A, TRUE, is the correct answer because it accurately reflects the relationship between lowering LDL-cholesterol levels and promoting regression of atherosclerotic plaques.
Options B, C, and D are incorrect:
- Option B, FALSE, is incorrect because the statement in the question is true, as explained above.
- Option C, None, is incorrect as there is a correct answer in this question.
- Option D, All the above, is incorrect as not all options are correct.
Educationally, understanding the impact of LDL-cholesterol on atherosclerosis and the role of agents that lower these levels is crucial for healthcare professionals involved in managing cardiovascular health. This knowledge helps in making informed decisions regarding pharmacological interventions to prevent and treat atherosclerosis-related conditions, ultimately improving patient outcomes.
Option A, TRUE, is the correct answer because it accurately reflects the relationship between lowering LDL-cholesterol levels and promoting regression of atherosclerotic plaques.
Options B, C, and D are incorrect:
- Option B, FALSE, is incorrect because the statement in the question is true, as explained above.
- Option C, None, is incorrect as there is a correct answer in this question.
- Option D, All the above, is incorrect as not all options are correct.
Educationally, understanding the impact of LDL-cholesterol on atherosclerosis and the role of agents that lower these levels is crucial for healthcare professionals involved in managing cardiovascular health. This knowledge helps in making informed decisions regarding pharmacological interventions to prevent and treat atherosclerosis-related conditions, ultimately improving patient outcomes.